Loading...

Entheon Biomedical Corp.

ENBI.CNCNQ
Healthcare
Biotechnology
CA$0.10
CA$-0.01(-12.50%)

Entheon Biomedical Corp. (ENBI.CN) Company Profile & Overview

Explore Entheon Biomedical Corp.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Entheon Biomedical Corp. (ENBI.CN) Company Profile & Overview

Entheon Biomedical Corp. operates as a biotechnology research and drug development company. It engages in developing and commercializing various N,N-dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. The company serves physicians, clinics, and licensed psychiatrists in Canada, the United States, and European Union. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.

SectorHealthcare
IndustryBiotechnology
CEOTimothy Ko

Contact Information

604-562-3932
999 West Broadway, Vancouver, BC, V5Z 1K5

Company Facts

1 Employees
IPO DateMay 3, 2018
CountryCA
Actively Trading

Frequently Asked Questions

;